@article{99d3b88772aa45d1863f170db27c600a,
title = "Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1",
author = "Warren Fiskus and Naval Daver and Steffen Boettcher and Mill, {Christopher P.} and Koji Sasaki and Birdwell, {Christine E.} and Davis, {John A.} and Kaberi Das and Koichi Takahashi and Kadia, {Tapan M.} and DiNardo, {Courtney D.} and Francis Burrows and Sanam Loghavi and Khoury, {Joseph D.} and Ebert, {Benjamin L.} and Bhalla, {Kapil N.}",
note = "Funding Information: The authors would like to thank the Sequencing and Microarray Core Facility, Flow Cytometry and Cellular Imaging (FCCI) Core Facility, which are supported by the MD Anderson Cancer Center Support Grant 5 P30 CA016672-40. KNB was supported by a grant from the NIH (R01 CA255721). This research is supported in part by the MD Anderson Cancer Center Leukemia SPORE (P50 CA100632). ",
year = "2022",
month = nov,
doi = "10.1038/s41375-022-01707-w",
language = "English (US)",
volume = "36",
pages = "2729--2733",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "11",
}